# Two less common human microRNAs miR-875 and miR-3144 target a conserved site of E6 oncogene in most high-risk human papillomavirus subtypes

## TL;DR

Two human microRNAs, miR-875 and miR-3144, target a conserved site in the E6 oncogene of high-risk human papillomaviruses, potentially offering a new approach for suppressing cervical cancer.

## Contribution

Identification of miR-875 and miR-3144 as novel human microRNAs targeting a conserved E6 oncogene site in most high-risk HPV subtypes.

## Key findings

- miR-875 and miR-3144 target a conserved site in the E6 oncogene of high-risk HPVs but not low-risk HPVs.
- These miRNAs suppress E6 oncogene expression and inhibit cell growth in HPV16-positive cervical cancer cells.
- The target site overlaps with an alternative splice exon in viral early transcripts.

## Abstract

Human papillomaviruses (HPVs) including high-risk (HR) and low-risk (LR) subtypes have distinguishable variation on both genotypes and phenotypes. The co-infection of multiple HR-HPVs, headed by HPV16, is common in cervical cancer in female. Recently accumulating reports have focused on the interaction between virus and host, particularly the role of human microRNAs (miRNAs) in anti-viral defense by targeting viral genome. Here, we found a well-conserved target site of miRNAs in the genomes of most HR-HPVs, not LR-HPVs, by scanning all potential target sites of human miRNAs on 24 HPVs of unambiguous subtypes of risk. The site is targeted by two less common human miRNAs, miR-875 and miR-3144, and is located in E6 oncogene open reading frame (ORF) and overlap with the first alternative splice exon of viral early transcripts. In validation tests, miR-875 and miR-3144 were identified to suppress the target reporter activity markedly and inhibit the expression of both synthetically exogenous E6 and endogenous E6 oncogene. High level of two miRNAs can inhibit cell growth and promote apoptosis in HPV16-positive cervical cancer cells. This study provides a promising common target of miRNAs for most HR-HPVs and highlights the effects of two low expressed human miRNAs on tumour suppression.